ID28
NameLC-MS
ClassificationAnalytical methods > Chromatography > Liquid chromatography (LC)

Publications with LC-MS

TitleFirst authorYear
Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortificationJohansson2010
Exploration of different methods to assess dietary acrylamide exposure in pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa)Brantsaeter2008
Tobacco smoking and urinary levels of 2-amino-9H-pyrido[2,3-b]indole in men of Shanghai, ChinaTuresky2007
Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomicsAndersen2014
Mass spectrometry-based metabolomics for the discovery of biomarkers of fruit and vegetable intake: citrus fruit as a case studyPujos-Guillot2013
Discovery of urinary biomarkers of whole grain rye intake in free-living subjects using nontargeted LC-MS metabolite profilingHanhineva2015
Novel multimetabolite prediction of walnut consumption by a urinary biomarker model in a free-living population: the PREDIMED studyGarcia-Aloy2014
Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countriesEdmands2015
New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjectsRothwell2014
Comparing metabolite profiles of habitual diet in serum and urinePlaydon2016
Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trialHanhineva2015
Nutrimetabolomics fingerprinting to identify biomarkers of bread exposure in a free-living population from the PREDIMED study cohortGarcia-Aloy2015
Discovery of exposure markers in urine for Brassica-containing meals served with different protein sources by UPLC-qTOF-MS untargeted metabolomicsAndersen2013
Serum Vitamin D and Risk of Breast Cancer within Five YearsO'Brien2017
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older menBarnett2010
Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black menLayne2017
Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohortFanidi2016
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohortMuller2014
Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control studyFedirko2014
Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studiesMeyer2013
Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly menTang2010
Plasma Riboflavin and Vitamin B-6, but Not Homocysteine, Folate, or Vitamin B-12, Are Inversely Associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese CohortAgnoli2016
One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolitesJohansson2009
Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case-control studyMichikawa2015
Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in JapanShimazu2011
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort studyWard2008
Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk studyWard2008
Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health CenterKurahashi2008
Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, ChinaLampe2007
Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health StudyLuo2010

Biomarker data

Measurements of biomarkers by LC-MS

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured by LC-MS and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured by LC-MS and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication